Abstract:for both the individual and society. Given the high prevalence of mental disorders globally, it is necessary to triage resources to those who need them most. Although undertreatment receives considerable attention, previous studies suggest that between one-third and half of the patients who are treated for mental disorders do not meet formal criteria for such disorders and that 3–14% of people without a mental disorder receive treatment for problems with emotions or the use of substances in a given year. However, these data are far from conclusive in arguing that a high proportion of treatment going to patients with low need. This is true for several reasons. First, most studies failed to assess other indicators of need for treatment besides diagnoses (for example recent stressors or suicidal behaviours). This is important because mental disorders are not the only indicators of need for treatment. Second, most previous studies did not provide information about the sector in which patients who failed to meet full criteria for a disorder received their treatment. This is important because treatment of such patients in the human services sector (such as spiritual counselling during normal bereavement) or the self-help sector (such as participation in a trauma survivor support group) would not be seen as inappropriate. Third, most of these studies were carried out in a small set of countries (mostly the USA, but also Canada Germany, The Netherlands, Chile and Australia). As far as we are aware, no global data exist that examines the proportion of treatment for problems with emotional issues or substance use received by those patients who fail to meet full criteria for a mental disorder. Such a study is especially timely in an era when governments, policymakers and healthcare planners face competing priorities and economic constraints. Data are reported here on these issues based on an analysis of data collected in the World Health Organization (WHO) World Mental Health (WMH) surveys. The WMH surveys are general population surveys that used structured psychiatric interviews, validated for use worldwide, to measure the presence of mental disorders as well as treatment for problems with emotions or for substance use. The current study builds on earlier WMH studies reporting on the crossnational treatment of mental disorders by investigating treatment of people without mental disorders. The specific aims of the study were to investigate the proportion of patients in treatment for problems with emotions or substance use at anytime in the 12 months before interview who failed to meet criteria for a DSM-IV disorder at any time during that 12-month period, to investigate other indicators of need among these patients, to examine the sectors of treatment as well as the frequency and duration of their use of services, and to examine their self-reported reasons for seeking treatment.

More Treatment, but Not Less Anxiety and Mood Disorders: Why? Seven Hypotheses and Their Evaluation

CHALLENGING THE MYTH OF AN “EPIDEMIC” OF COMMON MENTAL DISORDERS: TRENDS IN THE GLOBAL PREVALENCE OF ANXIETY AND DEPRESSION BETWEEN 1990 AND 2010

Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries

Respondents without mental disorders but with a need for treatment HIGH INCOME COUNTRIES MIDDLE INCOME COUNTRIES LOW INCOME COUNTRIES Respondents with lifetime mental disorders

Proportion of Patients Without Mental Disorders Being Treated in Mental Health Services Worldwide.

Frequency and quality of mental health treatment for affective and anxiety disorders among Australian adults

Perceived helpfulness of treatment for social anxiety disorder: findings from the WHO World Mental Health Surveys

Prevalence Increases as Treatments Improve: An Evolutionary Perspective on the Treatment–Prevalence Paradox in Depression

Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.

Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries

Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection

Characterising anxiety in major depressive disorder and its use in predicting antidepressant treatment outcome: An iSPOT-D report

Low stability of diagnostic classifications of anxiety disorders over time: A six-year follow-up of the NESDA study

Identification of latent classes in mood and anxiety disorders and their transitions over time: a follow-up study in the adult general population

Prevalence and Incidence Studies of Anxiety Disorders: A Systematic Review of the Literature

Predictors and moderators of outcome in child and adolescent anxiety and depression: a systematic review of psychological treatment studies

Social Anxiety Disorder: Individual Differences and Treatment

Predictors of Symptom Reduction and Remission Among People with Anxiety: Secondary Analyses from a Randomized Controlled Trial

Novel treatments for anxiety and depression: hurdles in bringing them to the market

Anxiety Disorders among Adolescents referred to General Psychiatry for Multiple Causes: Clinical Presentation, Prevalence, and Comorbidity